Virax Biolabs Group Overview
Virax Biolabs Group Discounted Cash Flow
DCF Analysis for VRAX.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.23
Current Fair Value
$1.23
↑ 570.3% Upside
Undervalued by 570.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison